Research & Literature

Live birth after autograft of ovarian tissue cryopreserved during childhood.

Demeestere I, Simon P, Dedeken L, et al.

Human reproduction (Oxford, England) 2015; (30(9)):2107-9 doi:10.1093/humrep/dev128.

The role of blood rheology in sickle cell disease.

Connes P, Alexy T, Detterich J, et al.

Blood reviews 2016; (30(2)):111-8.

Common gynecological challenges in adolescents with sickle cell disease.

Stimpson SJ, Rebele EC, DeBaun MR

Expert review of hematology 2016; (9(2)):187-96 doi:10.1586/17474086.2016.1126177.

Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.

Drawz P, Ayyappan S, Nouraie M, et al.

Clinical journal of the American Society of Nephrology : CJASN 2016; (11(2)):207-15 doi:10.2215/CJN.03940415.

Central nervous system complications and management in sickle cell disease.

DeBaun MR, Kirkham FJ

Blood 2016; (127(7)):829-38 doi:10.1182/blood-2015-09-618579.

Management of Sickle Cell Disease: Recommendations from the 2014 Expert Panel Report.

Yawn BP, John-Sowah J

American family physician 2015; (92(12)):1069-76.

Exploring Adult Care Experiences and Barriers to Transition in Adult Patients with Sickle Cell Disease.

Bemrich-Stolz CJ, Halanych JH, Howard TH, et al.

International journal of hematology & therapy 2015; (1(1)) doi:10.15436/2381-1404.15.003.

Clinical Management of Priapism: A Review.

Shigehara K, Namiki M

The world journal of men's health 2016; (34(1)):1-8 doi:10.5534/wjmh.2016.34.1.1.

Sudden Death in Sickle Cell Anaemia: Report of Three Cases with Brief Review of Literature.

Niraimathi M, Kar R, Jacob SE, Basu D

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2016; (32(Suppl 1)):258-61 doi:10.1007/s12288-015-0571-9.

Transfusion Therapy in Children With Sickle Cell Disease.

Inati A, Mansour AG, Sabbouh T, et al.

Journal of pediatric hematology/oncology 2017; (39(2)):126-132 doi:10.1097/MPH.0000000000000645.

Managing Acute Complications Of Sickle Cell Disease In Pediatric Patients.

Subramaniam S, Chao JH

Pediatric emergency medicine practice 2016; (13(11)):1-28.

Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease.

Cannas G, Poutrel S, Thomas X

Mediterranean journal of hematology and infectious diseases 2017; (9(1)):e2017015 doi:10.4084/MJHID.2017.015.

Recurrent Priapism Gone Wrong: ST-Elevation Myocardial Infarction and Cardiogenic Shock After Penile Corporal Phenylephrine Irrigation.

Constantine ST, Gopalsami A, Helland G

The Journal of emergency medicine 2017; (52(6)):859-862 doi:10.1016/j.jemermed.2017.01.055.

Evidence-Based Practice Standard Care for Acute Pain Management in Adults With Sickle Cell Disease in an Urgent Care Center.

Kim S, Brathwaite R, Kim O

Quality management in health care 2017; (26(2)):108-115 doi:10.1097/QMH.0000000000000135.

Paper-Based Diagnostics: Rethinking Conventional Sickle Cell Screening to Improve Access to High-Quality Health Care in Resource-Limited Settings.

Piety NZ, Shevkoplyas SS

IEEE pulse 2017; (8(3)):42-46 doi:10.1109/MPUL.2017.2678658.

Invasive Pneumococcal Disease in Patients With Sickle Cell Disease.

Navalkele P, Özgönenel B, McGrath E, et al.

Journal of pediatric hematology/oncology 2017; (39(5)):341-344 doi:10.1097/MPH.0000000000000858.

Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.

Kassim AA, Sharma D

Hematology/oncology and stem cell therapy 2017; (10(4)):259-266 doi:10.1016/j.hemonc.2017.05.008.

Transcranial color Doppler in stroke-free adult patients with sickle cell disease.

Graziadei G, Casoni FM, Annoni F, et al.

Annals of hematology 2017; (96(9)):1547-1555 doi:10.1007/s00277-017-3071-1.

Pattern of Cerebral Blood Flow Velocity Using Transcranial Doppler Ultrasonography in Children with Sickle Cell Disorder in Lagos State, Nigeria.

Adekunle MO, Animasahun AB, Diaku-Akinwumi IN, Njokanma OF

Mediterranean journal of hematology and infectious diseases 2017; (9(1)):e2017050 doi:10.4084/MJHID.2017.050.

CDC Grand Rounds: Improving the Lives of Persons with Sickle Cell Disease.

Hulihan M, Hassell KL, Raphael JL, et al.

MMWR. Morbidity and mortality weekly report 2017; (66(46)):1269-1271 doi:10.15585/mmwr.mm6646a2.

Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models.

Saraf SL, Sysol JR, Susma A, et al.

Translational research : the journal of laboratory and clinical medicine 2018; (197()):1-11 doi:10.1016/j.trsl.2018.01.007.

Autonomic nervous system involvement in sickle cell disease.

Coates TD, Chalacheva P, Zeltzer L, Khoo MCK

Clinical hemorheology and microcirculation 2018; (68(2-3)):251-262 doi:10.3233/CH-189011.

A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.

Niihara Y, Miller ST, Kanter J, et al.

The New England journal of medicine 2018; (379(3)):226-235 doi:10.1056/NEJMoa1715971.

[Total hip replacement in avascular femoral head necrosis].

Betsch M, Tingart M, Driessen A, et al.

Der Orthopade 2018; (47(9)):751-756 doi:10.1007/s00132-018-3617-5.

[Priapism: Diagnosis and management].

Carnicelli D, Akakpo W

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 2018; (28(14)):772-776 doi:10.1016/j.purol.2018.07.281.

Detection of hemoglobin variant HbS on the basis of discrepant HbA1c values in different measurement methods.

Takeda Y, Kawanami D, Utsunomiya K

Diabetology international 2016; (7(2)):199-203 doi:10.1007/s13340-015-0237-8.

Characterization of natural killer cells expressing markers associated with maturity and cytotoxicity in children and young adults with sickle cell disease.

Abraham AA, Lang H, Meier ER, et al.

Pediatric blood & cancer 2019; (66(5)):e27601 doi:10.1002/pbc.27601.

Recommendations for the use of red blood cell exchange in sickle cell disease.

Fort R

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2019; (58(2)):128-131 doi:10.1016/j.transci.2019.03.004.

Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates.

Yates AM, Joshi VM, Aygun B, et al.

Pediatric blood & cancer 2019; (66(7)):e27717 doi:10.1002/pbc.27717.

Implementation of an educational intervention to optimize self-management and transition readiness in young adults with sickle cell disease.

Calhoun CL, Abel RA, Pham HA, et al.

Pediatric blood & cancer 2019; (66(7)):e27722 doi:10.1002/pbc.27722.

Using Qualitative Perspectives of Adolescents with Sickle Cell Disease and Caregivers to Develop Healthcare Transition Programming.

Porter JS, Lopez AD, Wesley KM, et al.

Clinical practice in pediatric psychology 2017; (5(4)):319-329 doi:10.1037/cpp0000212.

Correlates of successful transition in young adults with sickle cell disease.

Darbari I, Jacobs E, Gordon O, et al.

Pediatric blood & cancer 2019; (66(12)):e27939 doi:10.1002/pbc.27939.

Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.

Alvarez OA, Hustace T, Voltaire M, et al.

Pediatrics 2019; (144(4)) doi:10.1542/peds.2018-4105.

Serum Immunoglobulin Levels in Children with Sickle Cell Disease: A Large Prospective Study.

Cherif-Alami S, Hau I, Arnaud C, et al.

Journal of clinical medicine 2019; (8(10)) doi:10.3390/jcm8101688.

Choice of Donor Source and Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Sickle Cell Disease.

Limerick E, Fitzhugh C

Journal of clinical medicine 2019; (8(11)) doi:10.3390/jcm8111997.

A program of transition to adult care for sickle cell disease.

Saulsberry AC, Porter JS, Hankins JS

Hematology. American Society of Hematology. Education Program 2019; (2019(1)):496-504 doi:10.1182/hematology.2019000054.

Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).

da Guarda CC, Yahouédéhou SCMA, Santiago RP, et al.

PloS one 2020; (15(1)):e0228399 doi:10.1371/journal.pone.0228399.

Laparoscopic cholecystectomy in children with sickle cell disease: A simple modified technique.

Al Hindi S, Al Aradi H, Mubarak M

Asian journal of endoscopic surgery 2020; (13(4)):514-518 doi:10.1111/ases.12789.

Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Estcourt LJ, Kimber C, Hopewell S, et al.

The Cochrane database of systematic reviews 2020; (4()):CD012389 doi:10.1002/14651858.CD012389.pub3.

Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties.

Garnier Y, Ferdinand S, Garnier M, et al.

Blood 2020; (136(2)):247-256 doi:10.1182/blood.2020004853.

American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.

DeBaun MR, Jordan LC, King AA, et al.

Blood advances 2020; (4(8)):1554-1588 doi:10.1182/bloodadvances.2019001142.

Sickle Cell Anemia in Cuba: Prevention and Management, 1982-2018.

Marcheco-Teruel B

MEDICC review 2019; (21(4)):34-38 doi:10.37757/MR2019.V21.N4.6.

Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease.

Han J, Saraf SL, Gordeuk VR

Pharmacotherapy 2020; (40(6)):535-543 doi:10.1002/phar.2409.

Acute care utilization in pediatric sickle cell disease and sickle cell trait in the USA: prevalence, temporal trends, and cost.

Peterson EE, Salemi JL, Dongarwar D, Salihu HM

European journal of pediatrics 2020; (179(11)):1701-1710 doi:10.1007/s00431-020-03656-x.

Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials.

Ali MA, Ahmad A, Chaudry H, et al.

Experimental hematology 2020; (92()):11-18.e1 doi:10.1016/j.exphem.2020.08.008.

Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries.

Desai RJ, Mahesri M, Globe D, et al.

Annals of hematology 2020; (99(11)):2497-2505 doi:10.1007/s00277-020-04233-w.

Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017.

Payne AB, Mehal JM, Chapman C, et al.

Annals of emergency medicine 2020; (76(3S)):S28-S36 doi:10.1016/j.annemergmed.2020.08.009.

Splenic sequestration in the adult: cross sectional imaging appearance of an uncommon diagnosis.

Esterson YB, Sheth S, Kawamoto S

Clinical imaging 2021; (69()):369-373 doi:10.1016/j.clinimag.2020.10.016.

Newborn Screening for SCD in the USA and Canada.

El-Haj N, Hoppe CC

International journal of neonatal screening 2018; (4(4)):36 doi:10.3390/ijns4040036.

Early Detection of Acute Chest Syndrome Through Electronic Recording and Analysis of Auscultatory Percussion.

Allen B, Molokie R, Royston TJ

IEEE journal of translational engineering in health and medicine 2020; (8()):4900108 doi:10.1109/JTEHM.2020.3027802.

Integrating Datasets on Public Health and Clinical Aspects of Sickle Cell Disease for Effective Community-Based Research and Practice.

Isokpehi RD, Johnson CP, Tucker AN, et al.

Diseases (Basel, Switzerland) 2020; (8(4)) doi:10.3390/diseases8040039.

Empirically Derived Profiles of Health-Related Quality of Life in Youth and Young Adults with Sickle Cell Disease.

Keenan ME, Loew M, Berlin KS, et al.

Journal of pediatric psychology 2021; (46(3)):293-303 doi:10.1093/jpepsy/jsaa104.

Matched sibling donor stem cell transplantation for sickle cell disease: Results from the Spanish group for bone marrow transplantation in children.

Benítez-Carabante MI, Beléndez C, González-Vicent M, et al.

European journal of haematology 2021; (106(3)):408-416 doi:10.1111/ejh.13566.

Hemoglobin Genotypes Modulate Inflammatory Response to Plasmodium Infection.

Harp KO, Botchway F, Dei-Adomakoh Y, et al.

Frontiers in immunology 2020; (11()):593546 doi:10.3389/fimmu.2020.593546.

Gene therapy for hemoglobinopathies.

Tanhehco YC

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2021; (60(1)):103061 doi:10.1016/j.transci.2021.103061.

Voxelotor: A Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease.

Yenamandra A, Marjoncu D

Journal of the advanced practitioner in oncology 2020; (11(8)):873-877 doi:10.6004/jadpro.2020.11.8.7.

Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review.

Knight LMJ, King AA, Strouse JJ, Tanabe P

Journal of pediatric hematology/oncology 2021; (43(3)):104-111 doi:10.1097/MPH.0000000000002091.

Case Report of Acute Splenic Sequestration Crisis in an Adult Patient with Hb S Disease and Suspected Hereditary Persistence of Fetal Hemoglobin.

Sigal IR, Ciunci CA

Hemoglobin 2021; (45(1)):60-61 doi:10.1080/03630269.2020.1868495.

Advances in neuroimaging to improve care in sickle cell disease.

Jordan LC, DeBaun MR, Donahue MJ

The Lancet. Neurology 2021; (20(5)):398-408 doi:10.1016/S1474-4422(20)30490-7.

Sickle Cell Disease in Jordan: The Experience of a Major Referral Center.

Oudat RI, Abualruz HS, Al-Shiek NKA, et al.

Medical archives (Sarajevo, Bosnia and Herzegovina) 2021; (75(1)):27-30 doi:10.5455/medarh.2021.75.27-30.

Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial.

Hood AM, Strong H, Nwankwo C, et al.

JMIR research protocols 2021; (10(5)):e27650 doi:10.2196/27650.

Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither.

Jones RJ, DeBaun MR

Blood 2021; (138(11)):942-947 doi:10.1182/blood.2021011488.

Adverse outcome of acute splenic sequestration crisis in pregnancy.

Malinowski AK, Parrish J, D'Souza R, et al.

Obstetric medicine 2021; (14(2)):113-115 doi:10.1177/1753495X20936902.

Acute Chest Syndrome, Avascular Necrosis of Femur, and Pulmonary Embolism All at Once: An Unexpected Encounter in the First-Ever Admission of a Sickle Cell Patient.

Annadatha A, Talwar D, Acharya S, et al.

Cureus 2021; (13(9)):e17656 doi:10.7759/cureus.17656.

Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.

Leonard A, Bertaina A, Bonfim C, et al.

Cytotherapy 2022; (24(3)):249-261 doi:10.1016/j.jcyt.2021.09.003.

Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.

Kanter J, Walters MC, Krishnamurti L, et al.

The New England journal of medicine 2022; (386(7)):617-628 doi:10.1056/NEJMoa2117175.

Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease.

Goyal S, Tisdale J, Schmidt M, et al.

The New England journal of medicine 2022; (386(2)):138-147 doi:10.1056/NEJMoa2109167.

The Epidemiology of Neurological Complications in Adults With Sickle Cell Disease: A Retrospective Cohort Study.

Maduakor C, Alakbarzade V, Sammaraiee Y, et al.

Frontiers in neurology 2021; (12()):744118 doi:10.3389/fneur.2021.744118.

MicroRNAs miR-451a and Let-7i-5p Profiles in Circulating Exosomes Vary among Individuals with Different Sickle Hemoglobin Genotypes and Malaria.

Oxendine Harp K, Bashi A, Botchway F, et al.

Journal of clinical medicine 2022; (11(3)) doi:10.3390/jcm11030500.

Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia✰,✰✰.

Heitzer AM, Longoria J, Rampersaud E, et al.

Current research in translational medicine 2022; (70(3)):103335 doi:10.1016/j.retram.2022.103335.

[Disease genotype, haplotypes, diagnosis and associated studies in sickle cell anemia].

Díaz-Matallana M, Márquez-Benítez Y, Martínez-Lozano JC, et al.

Revista medica de Chile 2021; (149(9)):1322-1329 doi:10.4067/S0034-98872021000901322.

Targeting fetal hemoglobin expression to treat β hemoglobinopathies.

Steinberg MH

Expert opinion on therapeutic targets 2022; (26(4)):347-359 doi:10.1080/14728222.2022.2066519.

Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review.

Dick MH, Abdelgadir A, Kulkarni VV, et al.

Cureus 2022; (14(5)):e24920 doi:10.7759/cureus.24920.

Incidence of Acute Chest Syndrome in Children With Sickle Cell Disease Following Implementation of the 13-Valent Pneumococcal Conjugate Vaccine in France.

Assad Z, Michel M, Valtuille Z, et al.

JAMA network open 2022; (5(8)):e2225141 doi:10.1001/jamanetworkopen.2022.25141.

Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa.

Smart LR, Ambrose EE, Balyorugulu G, et al.

Acta haematologica 2023; (146(2)):95-105 doi:10.1159/000526322.

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy.

Kassim AA, Leonard A

Journal of clinical medicine 2022; (11(16)) doi:10.3390/jcm11164775.

Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study.

Kanter J, Thompson AA, Pierciey FJ, et al.

American journal of hematology 2023; (98(1)):11-22 doi:10.1002/ajh.26741.

Vital Signs: Use of Recommended Health Care Measures to Prevent Selected Complications of Sickle Cell Anemia in Children and Adolescents - Selected U.S. States, 2019.

Schieve LA, Simmons GM, Payne AB, et al.

MMWR. Morbidity and mortality weekly report 2022; (71(39)):1241-1246 doi:10.15585/mmwr.mm7139e1.

Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease.

Alshurafa A, Yassin MA

Frontiers in medicine 2022; (9()):931924 doi:10.3389/fmed.2022.931924.

Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond.

Egesa WI, Nakalema G, Waibi WM, et al.

International journal of pediatrics 2022; (2022()):3885979 doi:10.1155/2022/3885979.

Stuttering Priapism in a Dog-First Report.

Roux FA, Le Breuil F, Branchereau J, Deschamps JY

Veterinary sciences 2022; (9(10)) doi:10.3390/vetsci9100518.

Acute Cholelithiasis With Acute Pancreatic Calcifications: A Unique Presentation of Sickle Cell Crisis.

Popat N, Kumar S, Unadkat BS

Cureus 2022; (14(10)):e30272 doi:10.7759/cureus.30272.

Blood plasma and bone marrow interstitial fluid metabolomics of sickle cell disease patients with osteonecrosis: An exploratory study to dissect biochemical alterations.

Pereira TCS, Souza AR, Daltro PB, et al.

Clinica chimica acta; international journal of clinical chemistry 2023; (539()):18-25 doi:10.1016/j.cca.2022.11.026.

Leg Ulcers in Sickle Cell Disease: A Multifactorial Analysis Highlights the Hemolytic Profile.

Santos EDC, Santana PVB, Jesus LLS, et al.

Hematology reports 2023; (15(1)):119-129 doi:10.3390/hematolrep15010013.

Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study.

Brandsen RP, Diederen RMH, Bakhlakh S, et al.

Blood advances 2023; (7(13)):3080-3086 doi:10.1182/bloodadvances.2022009147.

Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease.

Chauhan W, Zennadi R

Antioxidants (Basel, Switzerland) 2023; (12(3)) doi:10.3390/antiox12030740.

[Therapeutic approaches in sickle cell disease].

Joseph L, Arlet JB, Bernaudin F, Dhédin N

La Revue du praticien 2023; (73(5)):535-539.

Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.

Kobayashi M, Pilishvili T, Farrar JL, et al.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 2023; (72(3)):1-39 doi:10.15585/mmwr.rr7203a1.

Dermatologic complications in pediatric patients after hematopoietic stem cell transplantation for sickle cell disease.

Dignum T, Burroughs L, Mallhi K, Brandling-Bennett HA

Pediatric dermatology 2024; (41(1)):61-65 doi:10.1111/pde.15471.

Total hip replacement among sickle cell patients in a low-income country-Yemen.

Mughalles AA, Alkholidy GG, AlSaifi MS, et al.

International orthopaedics 2024; (48(4)):923-930 doi:10.1007/s00264-023-06049-5.

Frequency of Painful Crisis and Other Associated Complications of Sickle Cell Anemia Among Children.

Sendy JS, Alsadun MS, Alamer SS, et al.

Cureus 2023; (15(11)):e48115 doi:10.7759/cureus.48115.

Gene therapy for sickle cell disease.

Leonard A, Tisdale JF

Hematology. American Society of Hematology. Education Program 2023; (2023(1)):542-547 doi:10.1182/hematology.2023000487.

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia.

Parums DV

Medical science monitor : international medical journal of experimental and clinical research 2024; (30()):e944204 doi:10.12659/MSM.944204.

Cardiovascular consequences of sickle cell disease.

Palomarez A, Jha M, Medina Romero X, Horton RE

Biophysics reviews 2022; (3(3)):031302 doi:10.1063/5.0094650.

SARS-CoV-2 with Influenza B Coinfection in a Patient with Sickle Cell HbSC Presenting with Painful Crisis: A Case Report.

Ali EA, Fadul A, Subahi EA, et al.

Cureus 2024; (16(3)):e56102 doi:10.7759/cureus.56102.

Exagamglogene Autotemcel for Severe Sickle Cell Disease.

Frangoul H, Locatelli F, Sharma A, et al.

The New England journal of medicine 2024; (390(18)):1649-1662 doi:10.1056/NEJMoa2309676.

Controversies in the pathophysiology of leg ulcers in sickle cell disease.

Catella J, Guillot N, Nader E, et al.

British journal of haematology 2024; (205(1)):61-70 doi:10.1111/bjh.19584.

Splenic Sequestration Induced by Parvovirus B19: A Case Report.

Waleed S, Aldabsa M, Gouher S

Cureus 2024; (16(5)):e60937 doi:10.7759/cureus.60937.

Hospitalization Events Among Adolescents and Adults With Sickle Cell Disease in a Tertiary Care Center in Central India.

Wasnik P, Das P, Kumar A, et al.

Cureus 2024; (16(5)):e61185 doi:10.7759/cureus.61185.

Limited access to transcranial Doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey.

Voi V, Gutierrez-Valle V, Cuzzubbo D, et al.

Pediatric blood & cancer 2024; (71(10)):e31190 doi:10.1002/pbc.31190.

Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study.

Valle J, Lebensburger JD, Garimella PS, Gopal S

JMIR public health and surveillance 2024; (10()):e57290 doi:10.2196/57290.

[Sickle cell disease - common and dangerous complications].

Björkman H, Fager Ferrari M, Arvanitakis A, Kjellander C

Lakartidningen 2024; (121()).

Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease.

Singh A, Irfan H, Fatima E, et al.

Annals of medicine and surgery (2012) 2024; (86(8)):4555-4559 doi:10.1097/MS9.0000000000002146.

Total Hip Arthroplasty Following the Girdlestone Procedure in a Sickle Cell Disease Patient.

Alsaleem M, Al Abdrabalnabi HA, Al Furaikh BF, Althafar NA

Cureus 2024; (16(7)):e65240 doi:10.7759/cureus.65240.

Treating Sickle Cell Disease: Gene Therapy Approaches.

Cavazzana M, Corsia A, Brusson M, et al.

Annual review of pharmacology and toxicology 2025; (65(1)):397-413 doi:10.1146/annurev-pharmtox-022124-022000.

Fostering a healthier generation of children with sickle cell disease through advancements in care.

Franco E, Nimura C, McGann PT

Pediatric research 2025; (97(4)):1280-1289 doi:10.1038/s41390-024-03566-w.

Infrequent Resolution of Vaso-Occlusive Crises in Routine Clinical Care Among Patients Mimicking the Exa-Cel Trial Population: A Cohort Study of Medicaid Enrollees.

Mahesri M, Lee SB, Levin R, et al.

Clinical pharmacology and therapeutics 2024; (116(6)):1572-1579 doi:10.1002/cpt.3449.

Gene Therapies for Sickle Cell Disease.

Weaver SB, Singh D, Wilson KM

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians 2024; (40(5)):236-247 doi:10.1177/87551225241268742.

Avascular necrosis in sickle cell disease needs more definitive treatment options.

Galadanci NA, Kanter J

British journal of haematology 2025; (206(1)):385-386 doi:10.1111/bjh.19879.

CRISPR/Cas9 System as a Promising Therapy in Thalassemia and Sickle Cell Disease: A Systematic Review of Clinical Trials.

Ahmed R, Alghamdi WN, Alharbi FR, et al.

Molecular biotechnology 2026; (68(1)):23-32 doi:10.1007/s12033-025-01368-x.

Sickle cell disease gene therapy drug expenses and reimbursement: a litmus test for commercial pricing strategy and patient access for curative therapies.

Grilley BJ, Hume A, Galipeau J

Cytotherapy 2025; (27(5)):567-570 doi:10.1016/j.jcyt.2025.01.008.

Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI's Gene Therapy Access Model.

Zemplenyi A, Leonard J, Wright GC, et al.

PharmacoEconomics 2025; (43(5)):583-594 doi:10.1007/s40273-025-01474-3.

Best Practices in Gene Therapy for Sickle Cell Disease and Transfusion-dependent β-Thalassemia.

Frangoul H, Stults A, Bruce K, et al.

Transplantation and cellular therapy 2025; (31(6)):352.e1-352.e10 doi:10.1016/j.jtct.2025.02.025.

Confronting Cholelithiasis: A Case Series of Patients With Sickle Cell Disease and Gallstones.

Jagroo J, Oudit OA, Knowles C, Adidam Venkata S

Cureus 2025; (17(3)):e80558 doi:10.7759/cureus.80558.

Therapeutic promise of CRISPR-Cas9 gene editing in sickle cell disease and β-thalassemia: A current review.

Almasoudi HH

Current research in translational medicine 2025; (73(3)):103513 doi:10.1016/j.retram.2025.103513.

The Management of Ischemic Priapism Due to Sickle Cell Disease and Other Etiologies: Treatment Strategies and Indications for Penile Prosthesis Implantation in an Endemic Region.

Ördek E, Görür S, Gökalp F, et al.

Medicina (Kaunas, Lithuania) 2025; (61(4)) doi:10.3390/medicina61040658.

The microbiological characteristics and diagnosis of Streptococcus pneumoniae infection in the conjugate vaccine era.

Chen CH, Chen CL, Su LH, et al.

Human vaccines & immunotherapeutics 2025; (21(1)):2497611 doi:10.1080/21645515.2025.2497611.

Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies.

Yassin M, Minniti C, Shah N, et al.

Blood reviews 2025; (73()):101298 doi:10.1016/j.blre.2025.101298.

A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyurea.

Setayesh T, Chi M, Oestreicher Z, et al.

Blood 2025; (146(1)):13-28 doi:10.1182/blood.2024028136.

Variability in the Recommendations for Management of Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease: Review of Institutional Algorithms of Pediatric Hospitals Across the United States.

Elgehiny A, Quraishi MZ, Yadav A, et al.

Journal of pediatric hematology/oncology 2025; (47(5)):e155-e160 doi:10.1097/MPH.0000000000003052.

Emergency Presentations of Pediatric Sickle Cell Disease in French Guiana.

Djomo CF, Sile SN, Elenga N

Diseases (Basel, Switzerland) 2025; (13(5)) doi:10.3390/diseases13050142.

Optimizing Transcranial Doppler Screening for Stroke Prevention in Young African Children With Sickle Cell Disease.

Tembo D, Moons P, Tshimanga T, et al.

Pediatric blood & cancer 2025; (72(9)):e31861 doi:10.1002/pbc.31861.

Clinical Features and Outcomes of Pneumococcal Bacteremia in Children With Sickle Cell Disease in the Pneumococcal Conjugate Vaccine Era.

Yee ME, Abel L, Kalmus G, et al.

Pediatric blood & cancer 2025; (72(9)):e31881 doi:10.1002/pbc.31881.

Encephalitis Unraveled: The Unlikely Encounter of Sickle Cell Disease and Cerebral Malaria in a Teenager.

Ruff C, Zerweck L, Bevot A, et al.

Diagnostics (Basel, Switzerland) 2025; (15(12)) doi:10.3390/diagnostics15121470.

The racial politics of visibility and equity in genome-editing therapies for sickle cell disease.

Molina SJ, Creary M

Social science & medicine (1982) 2025; (383()):118452 doi:10.1016/j.socscimed.2025.118452.

Nalbuphine as a Potential Alternative to Morphine in Sickle Cell Disease Patients with Vaso-occlusive Crisis: A Retrospective Cohort Study.

Alghamdi M, Almulhim M, Almulihi Q, et al.

Saudi journal of medicine & medical sciences 2025; (13(3)):181-188 doi:10.4103/sjmms.sjmms_601_24.

De novo rates of a Trypanosoma-resistant mutation in two human populations.

Melamed D, Shemer R, Bolotin E, et al.

Proceedings of the National Academy of Sciences of the United States of America 2025; (122(35)):e2424538122 doi:10.1073/pnas.2424538122.

Encouraging Outcomes of Hematopoeitic Stem Cell Transplantation in Pediatric Sickle Cell Disease- A Decade-Long Experience from the Developing World.

Bhayana S, Chakaroborty S, Nathany S, et al.

Hemoglobin 2025; (49(5)):317-322 doi:10.1080/03630269.2025.2568129.

Hydroxyurea for Children with Sickle Cell Disease: A Practical Guide for Pediatric Clinicians.

Coyne F, Strouse JJ

Pediatric clinics of North America 2026; (73(1)):29-41 doi:10.1016/j.pcl.2025.08.007.

Gene Therapies for Hemoglobinopathies: Efficacy, Cell Collection & Transfusion Support.

Inam Z, Han H, Webb J, Delaney M

Transfusion medicine reviews 2025; (39(4)):150930 doi:10.1016/j.tmrv.2025.150930.

Opioid-Induced Pruritus: A Case Series on Novel Uses of Nalbuphine in the Emergency Department.

Muzaurieta AA, Semma YZ, Fernandes CC, et al.

Journal of the American College of Emergency Physicians open 2025; (6(6)):100266 doi:10.1016/j.acepjo.2025.100266.

Chronic Hydroxyurea Therapy in Children with Sickle Cell Anemia: Mechanisms of Action, Systemic Effects, and Long-Term Safety.

Fogliazza F, Berzieri M, Carbone G, et al.

Journal of clinical medicine 2025; (14(23)) doi:10.3390/jcm14238599.

Clinical data comparison for FDA-approved gene therapies in sickle cell disease.

Leonard A, Kanter J

Experimental biology and medicine (Maywood, N.J.) 2025; (250()):10806 doi:10.3389/ebm.2025.10806.

The GLOBE Trial: Efficacy and Safety of L-Glutamine Plus Hydroxyurea Versus Hydroxyurea Alone in Sickle Cell Anemia - A Double-Blind, Randomized Study.

Shakibazad N, Momenzadeh M, Amiri B, et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology 2026; doi:10.4274/tjh.galenos.2026.09709.

Newborn Screening for Hemoglobinopathies and Thalassemias: Brief History, Recent Activities, and Global Status-2026.

Therrell BL

International journal of neonatal screening 2026; (12(1)) doi:10.3390/ijns12010008.

Synergistic Potential of Thalidomide and Hydroxyurea in Sickle Cell Disease Management: A Promising Combination Therapy.

Samal P, Samal A, Lenka D, Bishoyi AK

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2026; (42(2)):370-377 doi:10.1007/s12288-025-02208-3.

Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation.

Testa U, Castelli G, Pelosi E

Journal of clinical medicine 2026; (15(4)) doi:10.3390/jcm15041379.

Current Status of Clinical Gene Therapy for Hemophilia and Globin Disorders.

Winkler R, Herath I, Kaczmarek R, et al.

Journal of blood medicine 2026; (17()):576017 doi:10.2147/JBM.S576017.